These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Duration of type I diabetes affects glucagon and glucose responses to insulin-induced hypoglycemia. Lorenzi M; Bohannon N; Tsalikian E; Karam JH West J Med; 1984 Oct; 141(4):467-71. PubMed ID: 6390972 [TBL] [Abstract][Full Text] [Related]
43. The induction of drug-metabolizing enzymes in rat liver during growth and regeneration. A biochemical and ultrastructural study. Chiesara E; Clementi F; Conti F; Meldolesi J Lab Invest; 1967 Feb; 16(2):254-67. PubMed ID: 6023784 [No Abstract] [Full Text] [Related]
44. Pharmacological properties of a new potential neuroleptic drug oxyprothepin. 3. Electroencephalographic study in rabbits. Likovský Z; Votava Z Act Nerv Super (Praha); 1971; 13(3):187-8. PubMed ID: 5113832 [No Abstract] [Full Text] [Related]
45. [Phenobarbital, difenin and trimetin effects on the blood sugar level]. Malygina EI Farmakol Toksikol; 1965; 28(6):725-7. PubMed ID: 5876379 [No Abstract] [Full Text] [Related]
46. [Kinetics of N-demethylation of amidopyrine with the supernatant portion of the centrifugate of new-born and adult rat liver in the presence of barbital, phenobarbital and phenylbutazone]. Klinger V Farmakol Toksikol; 1972; 35(1):63-8. PubMed ID: 5011520 [No Abstract] [Full Text] [Related]
47. [Psychopharmacological agents, hypnotics, anesthetics and analgesics in sleep therapy]. Arias Alvarez A Rev Esp Anestesiol Reanim; 1970 Apr; 17(2):289-301. PubMed ID: 5490508 [No Abstract] [Full Text] [Related]
48. Clinical evaluation of atarax; a non-barbiturate calming agent. ENDE M Va Med Mon (1918); 1956 Nov; 83(11):503-5. PubMed ID: 13371714 [No Abstract] [Full Text] [Related]
49. [Electroclinical characteristics of the effects of barbiturates on penicillin-induced epilepsy]. Popov I; Sterio D; Filipovic D; Lazetić B; Bajić M; Nikolić V Med Pregl; 1985; 38(9-10):439-41. PubMed ID: 4094585 [No Abstract] [Full Text] [Related]
52. Effect of temperature and barbiturates on a desynaptic mutant of ryegrass. Ahloowalia BS Mutat Res; 1969; 7(2):205-13. PubMed ID: 5796517 [No Abstract] [Full Text] [Related]
53. Effects of smoking on drug action. Miller RR Clin Pharmacol Ther; 1977 Nov; 22(5 Pt 2):749-56. PubMed ID: 913034 [No Abstract] [Full Text] [Related]
54. Body consciousness in states of pharmacological depression and arousal. Cassell WA; Hemingway P Neuropharmacology; 1970 Mar; 9(2):169-73. PubMed ID: 4909638 [No Abstract] [Full Text] [Related]
55. The phenobarbital sensitivity syndrome. MCGEACHY TE; BLOOMER WE Am J Med; 1953 May; 14(5):600-4. PubMed ID: 13040367 [No Abstract] [Full Text] [Related]
56. [Clinical course and therapy of acute luminal poisoning]. GEMBITSKII EV; SOBOLEV PI; BERLINER GB Sov Med; 1959 Jul; 23():102-6. PubMed ID: 13827244 [No Abstract] [Full Text] [Related]
57. [USE OF IPRONAL IN THE TREATMENT OF GLAUCOMA]. KAPUSCINSKI WJ; KRUDYSZ J; UHER M; SZYMANSKI J Wiad Lek; 1965 Feb; 18():321-3. PubMed ID: 14299990 [No Abstract] [Full Text] [Related]
58. [PAST RESULTS OF THE USE OF THE D1H PREPARATION (IPRONAL) IN SOME MENTAL DISORDERS]. ZYCHIEWICZ-KRANKOWSKA D Postepy Hig Med Dosw; 1963; 17():823-6. PubMed ID: 14125581 [No Abstract] [Full Text] [Related]